Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Filings indexed 262 across all filing types
Latest filing 2024-08-06 Report Publication Anno…
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It is not the presentation itself, but an announcement of the event and the availability of materials. Therefore, it falls under the category of a regulatory filing/announcement regarding corporate events.
2024-08-06 Korean
투자판단관련주요경영사항(임상시험계획자진취하등) (비소세포폐암 1차 치료제로 백토서팁 + 키트루다 병용 임상2상 조기 종료)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from MedPacto regarding the voluntary withdrawal of a Phase 2 clinical trial for a non-small cell lung cancer treatment. It details the clinical trial status, the reason for withdrawal (strategic shift in development), and regulatory confirmation. Since this is a specific regulatory disclosure regarding business operations and clinical trial status that does not fit into financial reporting or other specific categories like M&A or dividends, it is classified as a Regulatory Filing (RNS).
2024-08-05 Korean
투자판단관련주요경영사항(임상시험결과) (진행성 NSCLC를 대상으로 한 백토서팁과 더발루맙 병용요법의 제 1b/2a상, 공개시험 Top-line Data 결과 발표)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from MedPacto regarding the results of a clinical trial (Phase 1b/2a for Vactosertib and Durvalumab). It is structured as a formal 'Major Management Matter' (주요경영사항) disclosure, which is a standard regulatory filing format in South Korea for reporting material events such as clinical trial outcomes. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a formal regulatory disclosure of material information, it is classified as a Regulatory Filing (RNS).
2024-06-17 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for MedPacto, covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for MedPacto, dated 2024-03-28. It details the approval of financial statements, election of directors, and other resolutions passed during the meeting. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of changes in the company's board of directors or senior management.
2024-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.